SCHEDULE: Park Ha Biological Technology Stake Increases

Fusen Advertising Design Limited and Hao Meng report a combined 9.8% stake in Park Ha Biological Technology Co., Ltd. Class A Ordinary Shares.

Summary

• Fusen Advertising Design Limited and Hao Meng have jointly reported beneficial ownership of 422,500 Class A Ordinary Shares of Park Ha Biological Technology Co., Ltd.
• This holding represents 9.8% of the company's outstanding Class A Ordinary Shares.
• The calculation of the percentage is based on 2,297,902 shares outstanding post-reverse stock split effective August 6, 2026, and an additional 2,000,000 shares underlying warrants exercisable within 60 days.
• Fusen Advertising Design Limited is organized in Hong Kong, and Hao Meng is a citizen of China.
• Both reporting persons certify that the securities were not acquired or held for the purpose of influencing control of the issuer.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this filing as neutral to slightly positive, indicating a significant ownership stake by reporting persons without immediate implications for control changes.

Positives

• Significant combined ownership stake of 9.8% by Fusen Advertising Design Limited and Hao Meng.
• Warrants exercisable within 60 days suggest potential for increased future stake.
• Reporting persons certify no intent to influence or change control of the company.

Negatives

• The filing does not provide details on the acquisition cost or strategy behind the stake.
• The exact number of shares held by each entity is not explicitly separated in the summary, though cover page indicates 422,500 for each.

Risks

• Potential for increased shareholding if warrants are exercised.
• Future actions by these significant shareholders could impact share price or corporate strategy, though they certify no intent to influence control.

Future Outlook

The filing indicates potential for increased shareholding through the exercise of warrants within the next 60 days, which could bring the total beneficial ownership higher than the current 9.8%.

Management Comments

• "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under 240.14a-11."
• "After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct."

Industry Context

StockSavvy.ai notes that Schedule 13G filings typically indicate passive investment stakes. The context of Park Ha Biological Technology's sector (likely biotechnology, given the name) means that significant shifts in shareholding, even if passive, can be closely watched by the market.

Stakeholder Impact

• Shareholders: The increased stake by reporting persons may influence market perception and potentially future trading activity.
• Management: While reporting persons certify no intent to influence control, significant passive stakes can still draw management attention.

Next Steps

• Monitoring the exercise of warrants by Fusen Advertising Design Limited and Hao Meng.
• Observing any future filings or disclosures from these reporting persons regarding their stake in Park Ha Biological Technology Co., Ltd.

Key Dates

Keywords

Park Ha Biological Technology, Schedule 13G, Beneficial Ownership, Class A Ordinary Shares, Fusen Advertising Design Limited, Hao Meng, Warrants, Shareholder